Healthcare provider profile · identity verified

Luis Plasencia, M.D

Internal Medicine · MIAMI, FL · NPI 1265415939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	327	77
Atorvastatin Calcium	Atorvastatin Calcium	324	96
Levothyroxine Sodium	Levothyroxine Sodium	321	82
Amlodipine Besylate	Amlodipine Besylate	299	82
Losartan Potassium	Losartan Potassium	280	82
Lisinopril	Lisinopril	240	64
Hydrochlorothiazide	Hydrochlorothiazide	219	64
Omeprazole	Omeprazole	217	55
Famotidine	Famotidine	184	51
Alprazolam	Alprazolam	179	37
Sertraline Hcl	Sertraline Hcl	176	49
Metformin Hcl	Metformin Hcl	147	45
Trazodone Hcl	Trazodone Hcl	141	38
Pantoprazole Sodium	Pantoprazole Sodium	121	31
Olmesartan Medoxomil	Olmesartan Medoxomil	116	27
Metformin Hcl Er	Metformin Hcl	114	30
Temazepam	Temazepam	112	17
Gabapentin	Gabapentin	100	36
Metoprolol Tartrate	Metoprolol Tartrate	100	24
Eliquis	Apixaban	97	22
Memantine Hcl	Memantine Hcl	97	26
Atenolol	Atenolol	96	25
Azithromycin	Azithromycin	96	71
Furosemide	Furosemide	94	25
Rosuvastatin Calcium	Rosuvastatin Calcium	86	34
Escitalopram Oxalate	Escitalopram Oxalate	79	22
Carvedilol	Carvedilol	75	21
Fluticasone Propionate	Fluticasone Propionate	75	17
Simvastatin	Simvastatin	75	18
Tamsulosin Hcl	Tamsulosin Hcl	73	25
Albuterol Sulfate Hfa	Albuterol Sulfate	71	14
Meclizine Hcl	Meclizine Hcl	68	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	65	25
Allopurinol	Allopurinol	63	19
Clopidogrel	Clopidogrel Bisulfate	57	14
Finasteride	Finasteride	53	17
Diclofenac Sodium	Diclofenac Sodium	52	17
Glimepiride	Glimepiride	50	14
Montelukast Sodium	Montelukast Sodium	48	14
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Synthroid	Levothyroxine Sodium	46	15
Mupirocin	Mupirocin	45	22
Memantine Hcl Er	Memantine Hcl	43	suppressed
Xarelto	Rivaroxaban	41	suppressed
Sildenafil Citrate	Sildenafil Citrate	38	suppressed
Ssd	Silver Sulfadiazine	37	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Lorazepam	Lorazepam	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Meloxicam	Meloxicam	34	11
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Nitroglycerin	Nitroglycerin	30	13
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Tradjenta	Linagliptin	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Linzess	Linaclotide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Methocarbamol	Methocarbamol	19	11
Metronidazole	Metronidazole	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Valsartan	Valsartan	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Glipizide	Glipizide	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	15	suppressed
Diazepam	Diazepam	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ramipril	Ramipril	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Prednisone	Prednisone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Byetta	Exenatide	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Aliskiren	Aliskiren Hemifumarate	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Digoxin	Digoxin	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error